Effects of β1-integrin antisense phosphorothioate-modified oligonucleotide on myoblast behaviour in vitro

U. Carraro, A. Bruson, C. Catani, L. Dalla Libera, M. L. Massimino, C. Rizzi, K. Rossini, M. Sandri, M. Cantini

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Myoblasts gene-engineered in vitro and then injected in vivo are safe, efficient options for gene therapy. While isolation of satellite cells is routinely achieved, their proliferation potential in vitro remains a limiting factor for cell transplantation under clinical conditions. We have studied the role of reversible inhibition of gene expression by antisense oligonucleotides on the proliferation of the myogenic cells. Addition of antisense oligonucleotides to myoblast cultures has been used to inhibit specifically the expression of the β1-integrin subunit gene. Here we show that the effects of multiple pulses of a phosphorothioate oligodeoxinucleotide antisense on the attachment to substrata and on the proliferation of myoblasts are dose-dependent. The addition of antisense to rat myoblasts caused rounding up of the cells and most of the cells became detached after several days in culture. A single pulse did not show any consistent effect, while in the presence of continuously administered antisense, the relative numbers of myoblasts in the treated muscle culture increased. We have no evidence of inhibition of myoblast fusion under these conditions. On the other hand, [3H]-TdR incorporation, total DNA and total number of cells decreased in antisense-treated cultures thus demonstrating an inhibitory effect of the phosphorothioate oligonucleotides on DNA synthesis. These side-effects could be overcome by substituting the phosphorothioate by unmodified oligonucleotides, so decreasing the half-life of the antisense, but also its toxicity. The overall results suggest a potential role of integrin antisense strategy in modulating the potential of myoblasts to proliferate.

Original languageEnglish
Pages (from-to)99-104
Number of pages6
JournalCell Biochemistry and Function
Volume13
Issue number2
DOIs
Publication statusPublished - 1995

Fingerprint

Phosphorothioate Oligonucleotides
Antisense Oligonucleotides
Myoblasts
Integrins
Oligonucleotides
Genes
Gene therapy
DNA
Gene expression
Toxicity
Muscle
Rats
Fusion reactions
Satellites
Cell Separation
Cell Transplantation
In Vitro Techniques
Genetic Therapy
Half-Life
Cell Count

Keywords

  • Antisense
  • Gene therapy
  • Integrin
  • Myoblast
  • Proliferation

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology

Cite this

Carraro, U., Bruson, A., Catani, C., Dalla Libera, L., Massimino, M. L., Rizzi, C., ... Cantini, M. (1995). Effects of β1-integrin antisense phosphorothioate-modified oligonucleotide on myoblast behaviour in vitro. Cell Biochemistry and Function, 13(2), 99-104. https://doi.org/10.1002/cbf.290130206

Effects of β1-integrin antisense phosphorothioate-modified oligonucleotide on myoblast behaviour in vitro. / Carraro, U.; Bruson, A.; Catani, C.; Dalla Libera, L.; Massimino, M. L.; Rizzi, C.; Rossini, K.; Sandri, M.; Cantini, M.

In: Cell Biochemistry and Function, Vol. 13, No. 2, 1995, p. 99-104.

Research output: Contribution to journalArticle

Carraro, U, Bruson, A, Catani, C, Dalla Libera, L, Massimino, ML, Rizzi, C, Rossini, K, Sandri, M & Cantini, M 1995, 'Effects of β1-integrin antisense phosphorothioate-modified oligonucleotide on myoblast behaviour in vitro', Cell Biochemistry and Function, vol. 13, no. 2, pp. 99-104. https://doi.org/10.1002/cbf.290130206
Carraro, U. ; Bruson, A. ; Catani, C. ; Dalla Libera, L. ; Massimino, M. L. ; Rizzi, C. ; Rossini, K. ; Sandri, M. ; Cantini, M. / Effects of β1-integrin antisense phosphorothioate-modified oligonucleotide on myoblast behaviour in vitro. In: Cell Biochemistry and Function. 1995 ; Vol. 13, No. 2. pp. 99-104.
@article{236965dcde1b4929ad40fdcccf119f59,
title = "Effects of β1-integrin antisense phosphorothioate-modified oligonucleotide on myoblast behaviour in vitro",
abstract = "Myoblasts gene-engineered in vitro and then injected in vivo are safe, efficient options for gene therapy. While isolation of satellite cells is routinely achieved, their proliferation potential in vitro remains a limiting factor for cell transplantation under clinical conditions. We have studied the role of reversible inhibition of gene expression by antisense oligonucleotides on the proliferation of the myogenic cells. Addition of antisense oligonucleotides to myoblast cultures has been used to inhibit specifically the expression of the β1-integrin subunit gene. Here we show that the effects of multiple pulses of a phosphorothioate oligodeoxinucleotide antisense on the attachment to substrata and on the proliferation of myoblasts are dose-dependent. The addition of antisense to rat myoblasts caused rounding up of the cells and most of the cells became detached after several days in culture. A single pulse did not show any consistent effect, while in the presence of continuously administered antisense, the relative numbers of myoblasts in the treated muscle culture increased. We have no evidence of inhibition of myoblast fusion under these conditions. On the other hand, [3H]-TdR incorporation, total DNA and total number of cells decreased in antisense-treated cultures thus demonstrating an inhibitory effect of the phosphorothioate oligonucleotides on DNA synthesis. These side-effects could be overcome by substituting the phosphorothioate by unmodified oligonucleotides, so decreasing the half-life of the antisense, but also its toxicity. The overall results suggest a potential role of integrin antisense strategy in modulating the potential of myoblasts to proliferate.",
keywords = "Antisense, Gene therapy, Integrin, Myoblast, Proliferation",
author = "U. Carraro and A. Bruson and C. Catani and {Dalla Libera}, L. and Massimino, {M. L.} and C. Rizzi and K. Rossini and M. Sandri and M. Cantini",
year = "1995",
doi = "10.1002/cbf.290130206",
language = "English",
volume = "13",
pages = "99--104",
journal = "Cell Biochemistry and Function",
issn = "0263-6484",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Effects of β1-integrin antisense phosphorothioate-modified oligonucleotide on myoblast behaviour in vitro

AU - Carraro, U.

AU - Bruson, A.

AU - Catani, C.

AU - Dalla Libera, L.

AU - Massimino, M. L.

AU - Rizzi, C.

AU - Rossini, K.

AU - Sandri, M.

AU - Cantini, M.

PY - 1995

Y1 - 1995

N2 - Myoblasts gene-engineered in vitro and then injected in vivo are safe, efficient options for gene therapy. While isolation of satellite cells is routinely achieved, their proliferation potential in vitro remains a limiting factor for cell transplantation under clinical conditions. We have studied the role of reversible inhibition of gene expression by antisense oligonucleotides on the proliferation of the myogenic cells. Addition of antisense oligonucleotides to myoblast cultures has been used to inhibit specifically the expression of the β1-integrin subunit gene. Here we show that the effects of multiple pulses of a phosphorothioate oligodeoxinucleotide antisense on the attachment to substrata and on the proliferation of myoblasts are dose-dependent. The addition of antisense to rat myoblasts caused rounding up of the cells and most of the cells became detached after several days in culture. A single pulse did not show any consistent effect, while in the presence of continuously administered antisense, the relative numbers of myoblasts in the treated muscle culture increased. We have no evidence of inhibition of myoblast fusion under these conditions. On the other hand, [3H]-TdR incorporation, total DNA and total number of cells decreased in antisense-treated cultures thus demonstrating an inhibitory effect of the phosphorothioate oligonucleotides on DNA synthesis. These side-effects could be overcome by substituting the phosphorothioate by unmodified oligonucleotides, so decreasing the half-life of the antisense, but also its toxicity. The overall results suggest a potential role of integrin antisense strategy in modulating the potential of myoblasts to proliferate.

AB - Myoblasts gene-engineered in vitro and then injected in vivo are safe, efficient options for gene therapy. While isolation of satellite cells is routinely achieved, their proliferation potential in vitro remains a limiting factor for cell transplantation under clinical conditions. We have studied the role of reversible inhibition of gene expression by antisense oligonucleotides on the proliferation of the myogenic cells. Addition of antisense oligonucleotides to myoblast cultures has been used to inhibit specifically the expression of the β1-integrin subunit gene. Here we show that the effects of multiple pulses of a phosphorothioate oligodeoxinucleotide antisense on the attachment to substrata and on the proliferation of myoblasts are dose-dependent. The addition of antisense to rat myoblasts caused rounding up of the cells and most of the cells became detached after several days in culture. A single pulse did not show any consistent effect, while in the presence of continuously administered antisense, the relative numbers of myoblasts in the treated muscle culture increased. We have no evidence of inhibition of myoblast fusion under these conditions. On the other hand, [3H]-TdR incorporation, total DNA and total number of cells decreased in antisense-treated cultures thus demonstrating an inhibitory effect of the phosphorothioate oligonucleotides on DNA synthesis. These side-effects could be overcome by substituting the phosphorothioate by unmodified oligonucleotides, so decreasing the half-life of the antisense, but also its toxicity. The overall results suggest a potential role of integrin antisense strategy in modulating the potential of myoblasts to proliferate.

KW - Antisense

KW - Gene therapy

KW - Integrin

KW - Myoblast

KW - Proliferation

UR - http://www.scopus.com/inward/record.url?scp=0028988755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028988755&partnerID=8YFLogxK

U2 - 10.1002/cbf.290130206

DO - 10.1002/cbf.290130206

M3 - Article

VL - 13

SP - 99

EP - 104

JO - Cell Biochemistry and Function

JF - Cell Biochemistry and Function

SN - 0263-6484

IS - 2

ER -